We have witnessed the creation of thousands of
COVID-19-related regulatory updates in 2020. These
charts are generated from our OneSumX® for Regulatory
Change Management software that depicts the impact
COVID-19 has had on the regulatory landscape.
ComplianceMay 31, 2020
COVID-19-Related Regulatory Compliance Resource | May 2020 Review
Global Financial Services Synopsis
While COVID-19-related regulatory activity decreased from April to May, it comprised nearly 20% of worldwide financial industry regulatory activity last month. North
America and Europe are still producing the majority of COVID-19-related regulations, with 1,511 and 1,487 updates, respectively, since January 1, 2020.
U.S. Insurance Synopsis
Among U.S. Insurance companies, COVID-19-related regulatory activity declined slightly in May 2020 compared to April, but is still a dominant topic. Regulatory bodies
of Massachusetts, Pennsylvania, and Washington are now tied for producing the most updates since January 1, 2020. COVID-19 has impacted all business lines of U.S.
Insurance companies, but Commercial P&C and Health lines have experienced the most significant impact.
Sign up for Wolters Kluwer COVID-19 Regulatory Resource Bulletins
Related insights
Consolidated Appropriations Act, 2021: IRA distribution provisions included
Building clinical judgment during a pandemic: Exploring flexible foundational learning experiences that address the Next Generation NCLEX
The Corporate Transparency Act imposes new beneficial ownership reporting obligations on business entities
